Cue Biopharma (CUE) Equity Ratio (2017 - 2025)
Cue Biopharma (CUE) has disclosed Equity Ratio for 9 consecutive years, with 0.63 as the latest value for Q4 2025.
- Quarterly Equity Ratio rose 15.19% to 0.63 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.63 through Dec 2025, up 15.19% year-over-year, with the annual reading at 0.63 for FY2025, 15.19% up from the prior year.
- Equity Ratio hit 0.63 in Q4 2025 for Cue Biopharma, up from 0.42 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.81 in Q2 2021 to a low of 0.3 in Q1 2025.
- Historically, Equity Ratio has averaged 0.62 across 5 years, with a median of 0.63 in 2023.
- Biggest YoY gain for Equity Ratio was 15.19% in 2025; the steepest drop was 46.89% in 2025.
- Year by year, Equity Ratio stood at 0.79 in 2021, then fell by 8.37% to 0.72 in 2022, then decreased by 16.24% to 0.6 in 2023, then decreased by 9.81% to 0.54 in 2024, then rose by 15.19% to 0.63 in 2025.
- Business Quant data shows Equity Ratio for CUE at 0.63 in Q4 2025, 0.42 in Q3 2025, and 0.45 in Q2 2025.